PA Medical News about lung cancer; RFA

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Use of Antiemetic Agents in Acute Gastroenteritis

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

RFA is an effective alternative to lobectomy for lung cancer
JAAPA, 02/02/09

Cackler S et al. - Primary care providers often diagnose or locate lung lesions on routine chest radiographs and, in many cases, are included in treatment discussions with patients. For this reason, PAs in all fields should be aware of the different treatment options available. In most centers, lobectomy remains the preferential treatment for NSCLC, but now other treatment options are available for those patients who are poor candidates for resection. RFA causes the destruction of lung tumors. The procedure is performed under local anesthesia and produces limited toxicity to adjacent tissue. RFA offers localized control of the tumor and preservation of vital, unaffected lung tissue in higher-risk patient groups. Increased risk is associated with prohibitive lung function or serious comorbid illnesses.